SHANNON MALE: Open Payments
NPI 1396246401 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,494 in 65 payments from 31 companies in 2025. Trend: 2023 $1,502 · 2024 $1,445 · 2025 $1,494
Food & beverage: $1,403Education: $91
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $119 |
| Merck Sharp & Dohme LLC | 5 | $105 |
| Eisai Inc. | 5 | $97 |
| Daiichi Sankyo Inc. | 4 | $95 |
| BeOne Medicines USA, Inc. | 3 | $95 |
| SANOFI-AVENTIS U.S. LLC | 1 | $91 |
| Celgene Corporation | 3 | $82 |
| PFIZER INC. | 3 | $61 |
| Lilly USA, LLC | 2 | $58 |
| JAZZ PHARMACEUTICALS INC. | 2 | $56 |
Products named: Enhertu, Lenvima, BRUKINSA, SARCLISA, KEYTRUDA, REBLOZYL, IBRANCE, VERZENIO.
Industry payments across IL — which companies pay providers there.
